GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Loans Receivable

Actinogen Medical (ASX:ACW) Loans Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Loans Receivable?

Actinogen Medical's Loans Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Actinogen Medical Loans Receivable Historical Data

The historical data trend for Actinogen Medical's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Loans Receivable Chart

Actinogen Medical Annual Data
Trend Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Actinogen Medical Semi-Annual Data
Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Actinogen Medical Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Actinogen Medical Loans Receivable Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinogen Medical Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Actinogen Medical Headlines

From GuruFocus

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish 10-13-2014

Stocks That Are Making A Good Come Back

By reports.droy reports.droy 03-10-2015